Dr.Ling Yin is an Associate Professor at the Institute of Health and Medicine, Hefei Comprehensive National Science Center. She holds a Ph.D. in Vegetable Genetics and Breeding from South China Agricultural University (2016), where she studied glucoraphanin biosynthesis in Chinese kale, and a B.S. in Plant Science from Qingdao Agricultural University (2009).

Dr.Yin's research focuses on cancer therapeutics and inflammation, leveraging gene therapy and molecular biology to bridge basic science and clinical applications. Her work integrates genomics, immunology, and precision medicine, exemplified by her development of AAV-based delivery systems for liver cancer treatment (Gene Therapy, 2021) and investigations into NLRP3 inflammasome mechanisms (Drug Discovery Today, 2025). She has held positions at the University of Florida (Postdoctoral Associate, 2021 2022; Biological Scientist II, 2022-2025) and mentored graduate and undergraduate students.

A recognized expert in her field, Dr.Yin serves as an editor for multiple international journals (e.g., Cancer Treatment and Survivorship, The European Journal of Cancer) and has been invited to speak at global conferences. She has received awards such as the "Class E High-Caliber Talent of Anhui Province" (2025) and the "Global Recognition Award" (2024).